A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2002
12/19/2002	US20020192282 Multilayer pharmaceutical product for release in the colon
12/19/2002	US20020192281 Beta-lactam antibiotic-containing tablet and production thereof
12/19/2002	US20020192280 Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
12/19/2002	US20020192279 Method for producing antibiotic composites
12/19/2002	US20020192278 Filler binder for tablets
12/19/2002	US20020192277 Controlled release hydrocodone formulations
12/19/2002	US20020192276 Use of G class immunoglobulins for the topical treatment of atopic dermatitis
12/19/2002	US20020192275 Liposome composition for improved intracellular delivery of a therapeutic agent
12/19/2002	US20020192274 pH sensitive liposomal drug delivery
12/19/2002	US20020192273 Therapeutic patch useful for the treatment of hemorrhoids
12/19/2002	US20020192272 Metronidazole pledgets
12/19/2002	US20020192268 Substrates utilizing shear responsive micropockets for storage and delivery of substances
12/19/2002	US20020192254 Oil in water emulsion; skin absorption; containing maracalcitol
12/19/2002	US20020192251 Cosmetic composition containing a mixture of fibers
12/19/2002	US20020192243 Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
12/19/2002	US20020192242 Bone disorders; drug delivery; mixture of bone density regulator and base
12/19/2002	US20020192241 Methods of using kavalactone compositions
12/19/2002	US20020192235 Novel vitamin b12 - biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines
12/19/2002	US20020192207 Pharmaceutical compositions of fibrinolytic agent
12/19/2002	US20020192202 Probiotic compounds derived from lactobacillus casei strain KE01
12/19/2002	US20020192190 Induction of immunological tolerance
12/19/2002	US20020192166 Mousse forming hair treatment composition
12/19/2002	US20020192165 Aerosol compositions comprising a polysaccharide grafted with a polysiloxane
12/19/2002	US20020192164 Methods and compositions for the pulmonary delivery insulin
12/19/2002	US20020192161 Animal model for evaluating analgesics
12/19/2002	US20020192157 Treatment and diagnosis of macrophage mediated disease
12/19/2002	US20020189610 Pharmaceutical compositions containing an ipratropium salt and a betamimetic
12/19/2002	US20020189454 Method for capturing fine particles by percolation in a bed of granules
12/19/2002	DE4447770C2 Verfahren zur Herstellung von liposomal verkapseltem Taxol Process for the preparation of liposomally encapsulated Taxol
12/19/2002	DE10137876A1 Behandelte wasserunlösliche Feststoffteilchen, ihre Herstellung und Verwendung Treated water-insoluble solid particles, their preparation and use
12/19/2002	DE10128685A1 Self-adhesive sticking plaster matrix material comprising active material and penetration enhancer, useful for skin care, especially controlled application of active material to skin
12/19/2002	DE10127897A1 Combined pharmaceutical formulation for treating osteoporosis or related disorders, comprising core of dried plant extract enclosed in sheath of calcium salt
12/19/2002	DE10127712A1 Use of immunoglobulin M for treatment and prevention of systemic lupus erythematosus, administered subcutaneously or intramuscularly
12/19/2002	DE10127455A1 Transdermal therapeutic system, preferably of reservoir or matrix type, has peelable film with reduced tear strength in one dimension
12/19/2002	CA2852202A1 Calcium phosphate delivery vehicles for osteoinductive proteins
12/19/2002	CA2488850A1 Sustained release n-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating cancer
12/19/2002	CA2450366A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
12/19/2002	CA2450238A1 Oral pharmaceutical composition containing a statin derivative
12/19/2002	CA2450131A1 Respiratory syncytial virus
12/19/2002	CA2449731A1 Functional grain-containing preparations quickly disintegrated in the oral cavity
12/19/2002	CA2449673A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	CA2449593A1 Spray freeze-dried compositions
12/19/2002	CA2449571A1 Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
12/19/2002	CA2449519A1 Controlled release dosage forms using acrylic polymer, and process for making the same
12/19/2002	CA2449213A1 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	CA2448543A1 Breath protection microcapsules
12/19/2002	CA2447891A1 Exothermic formulations for the treatment of ectoparasites
12/19/2002	CA2447557A1 Using supercritical fluids to infuse therapeutic on a medical device
12/19/2002	CA2446223A1 Stabilized dispersion of phytosterol in oil
12/18/2002	WO2001097784A1 Process for producing phospholipid-containing drugs
12/18/2002	EP1266657A1 Cyclodextrin stabilized pharmaceutical compositions of bupropion hydrochloride
12/18/2002	EP1266656A1 Anionic exchange polymer complexes of buspirone
12/18/2002	EP1266655A1 Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component
12/18/2002	EP1266654A1 Stabilised amlodipine maleate formulations
12/18/2002	EP1266220A2 Biomedical assay device
12/18/2002	EP1265983A1 Particles containing coated living micro-organisms, and method for producing same
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
12/18/2002	EP1265698A1 Lipid nanocapsules, preparation method and use as medicine
12/18/2002	EP1265683A1 Methods for extraction and reaction using supercritical fluids
12/18/2002	EP1265648A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such
12/18/2002	EP1265638A1 Compositions for transdermal and transmucosal administration of therapeutic agents
12/18/2002	EP1265637A2 Compositions and methods for affecting osteogenesis
12/18/2002	EP1265630A2 Use of insulin for the treatment of cartilagenous disorders
12/18/2002	EP1265618A1 Anaesthetic composition
12/18/2002	EP1265617A2 Novel topical oestroprogestational compositions with systemic effect
12/18/2002	EP1265615A2 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis
12/18/2002	EP1265614A1 Novel galenical form for oral administration with prolonged release of molsidomine
12/18/2002	EP1265612A1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid
12/18/2002	EP1265610A1 Method for reducing or eliminating smoking
12/18/2002	EP1265609A1 Methods for treating sexual dysfunction with apomorphine at specified plasma concentration levels
12/18/2002	EP1265608A2 Oxazolidinone tablet formulation
12/18/2002	EP1265600A2 Headache and colic relief composition with asafetida and method of use thereof
12/18/2002	EP1265599A1 Antibiotic composition with inhibitor
12/18/2002	EP1265598A1 Pharmaceutical composition for application to mucosal surfaces
12/18/2002	EP1265597A2 Homogenous solid matrix containing vegetable proteins
12/18/2002	EP1265596A2 Medical emulsion for lubrication and delivery of drugs
12/18/2002	EP1265595A2 Stabilized ascorbic acid solutions
12/18/2002	EP1265579A1 Container for linezolid intravenous solution
12/18/2002	EP1265570A1 Soluble keratin peptide
12/18/2002	EP1265493A2 A method and apparatus for coating centers
12/18/2002	EP1121088B1 Use of nanoscale sterols and sterol esters
12/18/2002	EP1068240B1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
12/18/2002	EP1021180B1 Mixed cyanoacrylate ester compositions
12/18/2002	EP0989847B1 Anti-tumoral therapy agent
12/18/2002	EP0938331B1 Therapeutic uses of bpi protein products in cystic fibrosis patients
12/18/2002	EP0938301B1 Directly compressible lactitol and method
12/18/2002	EP0934078B1 Permeation enhancers for transdermal drug delivery compositions, devices, and methods
12/18/2002	EP0904121B1 Secondary shaping of ionically cross-linked polymer compositions for medical devices
12/18/2002	EP0866803B1 Transferrin receptor protein of moraxella
12/18/2002	EP0836506B1 Transdermal patch for administering 17-deacetyl norgestimate alone or in combination with an estrogen
12/18/2002	EP0789583B1 Methods and kits using macrophage stimulating protein
12/18/2002	EP0788792B1 Matrix type patch preparation
12/18/2002	EP0784485B1 VACCINE COMPOSITIONS containing partially deacetylated chitin
12/18/2002	EP0736002B9 Compound capable of introducing at least one molecule into a cell
12/18/2002	EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy
12/18/2002	CN1386065A Membr for application of ointment and ointment patch employing the same
12/18/2002	CN1386064A Granules based on starch and lactose
12/18/2002	CN1386063A Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides
12/18/2002	CN1385425A Different crystalyzed (-)-6-chloro-4-cyclopropyl ethinyl-4-trifluoride-1,4-dihydro-2H-3,1-benzoxazine-2-ketone
12/18/2002	CN1385201A Formula of solid antitussive soft-extract and preparation method thereof

1 ... 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 ... 2991